Friday, 30 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14778
Articles
Company
Deals
GSC to Distribute Hecin’s Innovative PCR and RT-PCR Solutions in Middle Eastern Markets
October 13, 2024
Company
WuXi Biologics Reports Flat Revenues with Growth in Non-COVID-19 Projects in 2024H1 Financial Report
October 13, 2024
Company
Drug
Innovent Biologics’ Fulzerasib Receives NMPA Approval for Advanced NSCLC Treatment in China
October 13, 2024
Policy / Regulatory
China’s NHC and NHSA Intensify Efforts to Stabilize Drug Supply and Prices Amid Shortages
October 13, 2024
Policy / Regulatory
China Commits to Optimizing Market Access for Emerging Sectors and Global Scientific Collaboration
October 13, 2024
Company
Drug
Qilu Pharmaceutical’s Biosimilar Ranibizumab Receives NMPA Approval, Marking a First in China
October 13, 2024
Company
Drug
BrightGene Bio Receives FDA Clearance for Generic Eribulin APIs, Advancing in Breast Cancer Treatment
December 1, 2024
Company
Sisram Medical Reports 2024 Interim Revenues with Growth in Key Regions and New Product Launches
October 13, 2024
Company
Drug
Daiichi Sankyo Launches Tarlige for Diabetes Peripheral Neuropathic Pain in China
October 13, 2024
Company
Deals
Changchun GeneScience Pharmaceutical Expands Reach with HuChuang Union Partnership
October 13, 2024
Company
Deals
SynthAsia and Shanghai General Hospital Partner to Advance Diabetic Retinopathy Research
October 13, 2024
Company
Jiangsu Hengrui Pharmaceuticals Reports 21.78% YOY Revenue Growth and 48.67% Increase in Net Profit for H1 2024
December 3, 2024
1
2
…
638
639
640
641
642
…
1,231
1,232
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?